Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Tumor vessels-radiotherapy interaction and nanomedicines interventiona review.

Created on 19 Sep 2026

Authors

Tong Fu, Yichen Zhao, Yuao Zhang, Yun Lu, Haowen Pang, Shaozhi Fu

Published in

International journal of pharmaceutics. Pages 127430. Sep 18, 2026. Epub Sep 18, 2026.

Abstract

Radiotherapy is one of the key modalities for the clinical management of malignant tumors. It not only directly kills cancer cells but also exerts significant effects on the tumor microenvironment (TME). Conversely, the TME also has a substantial impact on the outcomes of radiotherapy and other regiments, and is closely associated with patient prognosis. As a critical component of the TME, tumor blood vessels participate in various stages of tumorigenesis and progression, and markedly modulate the efficacy of radiotherapy. The advent of nanomedicines has greatly facilitated radiotherapy sensitization and enabled precise remodeling of the tumor vasculature. Accordingly, this review first outlines vascular features within solid tumors, discusses the effects of different radiation doses on tumor vasculature, and further dissects vascular modulation strategies combining nanomedicines with radiotherapy. We further highlight the key barriers to clinical translation and outline prospective research directions, aiming to offer theoretical support for refined radiotherapy regimens and the development of vasculature-targeted nanomedicines.

PMID:
42759671
Bibliographic data and abstract were imported from PubMed on 19 Sep 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 13
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement